Pacira BioSciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pacira BioSciences using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $0.70 | $0.56 | 25.0 % |
| Q2 | 2025-08-05 | $0.74 | $0.62 | 19.4 % |
| Q1 | 2025-05-08 | $0.62 | $0.60 | 3.33 % |
| Q4 | 2025-02-27 | $0.91 | $0.83 | 9.64 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $179.52M | $182.38M | -1.57 % |
| Q2 | 2025-08-05 | $181.10M | $183.35M | -1.23 % |
| Q1 | 2025-05-08 | $168.92M | $175.88M | -3.96 % |
| Q4 | 2025-02-27 | $187.25M | $185.38M | 1.01 % |
Pacira BioSciences (PCRX) is scheduled to report earnings on February 26, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.
The Actual EPS was $0.70, which beat the estimate of $0.56.
The Actual Revenue was $179.5M, which missed the estimate of $182.4M.
Browse earnings estimates, EPS, and revenue on all stocks.